Skip to main navigation Skip to search Skip to main content

Effects of teriflunomide (Aubagio) on gray matter pathology in multiple sclerosis - a 12 months, prospective, observational, single-blinded, longitudinal study

    Project: Research

    Project Details

    StatusActive
    Effective start/end date07/1/13 → …